A novel PET imaging probe detects tumor cell death in vivo and could be useful for personalizing cancer medicine.

Having a “leaky” gut may protect against colitis, a paradoxical finding that alters understanding of the role of cell permeability in intestinal homeostasis and immune regulation.

Vanderbilt researchers have discovered small molecules that turn off cancerous Ras signals in a new way.

Targeting the production of molecules that promote tumor blood vessel development offers a new path for treating lung cancer.

Harold “Hal” Moses, the Hortense B. the Ingram Professor of Cancer Research at Vanderbilt University, is the recipient of the 2014 Distinguished Alumni Award — the highest honor for a member of the Vanderbilt alumni community.

A metabolic enzyme plays a crucial role in vascular development and may be a good target for cancer therapies.